<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="nutrj" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC4609100/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609100/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Nutrition Journal" /><meta name="citation_title" content="The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials" /><meta name="citation_authors" content="Arjuna B. Medagama" /><meta name="citation_date" content="2015" /><meta name="citation_volume" content="14" /><meta name="citation_doi" content="10.1186/s12937-015-0098-9" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4609100/?report=abstract" /><meta name="citation_pmid" content="26475130" /><meta name="DC.Title" content="The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Arjuna B. Medagama" /><meta name="DC.Date" content="2015" /><meta name="DC.Identifier" content="10.1186/s12937-015-0098-9" /><meta name="DC.Language" content="en" /><meta property="og:title" content="The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials" /><meta property="og:type" content="article" /><meta property="og:description" content="Cinnamon is currently marketed as a remedy for obesity, glucose intolerance, diabetes mellitus and dyslipidaemia. Integrative medicine is a new concept that combines conventional treatment with evidence-based complementary therapies.The aim of this review ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609100/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-nutrj.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4609100/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4609100/pdf/12937_2015_Article_98.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FB3FE3B9231B810000000000040004.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/128/">Nutr J</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/247585/">v.14; 2015</a></li><li class="accid">PMC4609100</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-nutrj.png" alt="Logo of nutrj" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,162,75" alt="BioMed Central" title="BioMed Central" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,0,99,74" alt="Biomed Central Web Site" title="Biomed Central Web Site" href="http://www.biomedcentral.com" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="247,59,296,75" alt="search" title="search" href="http://www.nutritionj.com/search" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="301,59,405,75" alt="submit a manuscript" title="submit a manuscript" href="http://www.nutritionj.com/manuscript" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="415,59,458,75" alt="register" title="register" href="http://www.nutritionj.com/register" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="185,59,244,75" alt="this article" title="this article" href="//dx.doi.org/10.1186/s12937-015-0098-9" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,0,480,75" alt="Nutrition Journal" title="Nutrition Journal" href="http://www.nutritionj.com" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,0,480,74" alt="Journal Front Page" title="Journal Front Page" href="http://www.nutritionj.com" ref="reftype=publisher&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Nutr J</span>. 2015; 14: 108. </span></div><div><span class="fm-vol-iss-date">Published online 2015 Oct 16. </span>  <span class="doi">doi:  <a href="//dx.doi.org/10.1186%2Fs12937-015-0098-9" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1186/s12937-015-0098-9</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4609100</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/26475130">26475130</a></div></div></div></div></div><h1 class="content-title">The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Medagama%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26475130" class="affpopup" co-rid="_co_idm140320722475264" co-class="co-affbox">Arjuna B. Medagama</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140320722475264"><h3 class="no_margin">Arjuna B. Medagama</h3><p>Department of Medicine, Senior Lecturer in Medicine, University of Peradeniya, Peradeniya, Sri Lanka </p><div>Find articles by <a href="/pubmed/?term=Medagama%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26475130">Arjuna B. Medagama</a></div></div></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140320762018320_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1">Department of Medicine, Senior Lecturer in Medicine, University of Peradeniya, Peradeniya, Sri Lanka </div><div><span class="fm-affl">Arjuna B. Medagama, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@amagadem.anujra" class="oemail">moc.liamg@amagadem.anujra</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm140320762018320_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140320762018320_an">Article notes <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140320762018320_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140320762018320_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2015 Jul 18; Accepted 2015 Oct 9.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140320762018320_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Medagama. 2015</div><div class="fm-copyright half_rhythm"><div class="license"><strong>Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href="http://creativecommons.org/licenses/by/4.0/" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href="http://creativecommons.org/publicdomain/zero/1.0/" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</div></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>This article has been <a href="/pmc/articles/PMC4609100/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h2>Introduction</h2><p id="__p1" class="p p-first-last">Cinnamon is currently marketed as a remedy for obesity, glucose intolerance, diabetes mellitus and dyslipidaemia. Integrative medicine is a new concept that combines conventional treatment with evidence-based complementary therapies.</p></div><div id="__sec2" class="sec"><h2>Aim</h2><p id="__p2" class="p p-first-last">The aim of this review is to critically evaluate the experimental evidence available for cinnamon in improving glycaemic targets in animal models and humans.</p></div><div id="__sec3" class="sec"><h2>Results</h2><p id="__p3" class="p p-first">Insulin receptor auto-phosphorlylation and de-phosphorylation, glucose transporter 4 (GLUT-4 ) receptor synthesis and translocation, modulation of hepatic glucose metabolism through changes in Pyruvate kinase (PK) and Phosphenol Pyruvate Carboxikinase (PEPCK), altering the expression of PPAR (&#x003b3;) and inhibition of intestinal glucosidases are some of the mechanisms responsible for improving glycaemic control with cinnamon therapy.</p><p id="__p4" class="p p-last">We reviewed 8 clinical trials that used <em>Cinnamomum cassia</em> in aqueous or powder form in doses ranging from 500&#x000a0;mg to 6&#x000a0;g per day for a duration lasting from 40&#x000a0;days to 4&#x000a0;months as well as 2 clinical trials that used cinnamon on treatment na&#x000ef;ve patients with pre-diabetes. An improvement in glycaemic control was seen in patients who received Cinnamon as the sole therapy for diabetes, those with pre-diabetes (IFG or IGT) and in those with high pre-treatment HbA1c. In animal models, cinnamon reduced fasting and postprandial plasma glucose and HbA1c.</p></div><div id="__sec4" class="sec sec-last"><h2>Conclusion</h2><p id="__p5" class="p p-first-last">Cinnamon has the potential to be a useful add-on therapy in the discipline of integrative medicine in managing type 2 diabetes. At present the evidence is inconclusive and long-term trials aiming to establish the efficacy and safety of cinnamon is needed. However, high coumarin content of <em>Cinnamomum cassia</em> is a concern, but <em>Cinnamomum zeylanicum</em> with its low coumarin content would be a safer alternate.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Type 2 diabetes mellitus, Impaired fasting glucose, Cinnamon, Glucose transporter type 4 (GLUT4), Coumarins, Glycaemic control</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><div id="Sec2" class="sec sec-first"><h3>Cinnamon</h3><p id="__p6" class="p p-first"><em>Cinnamon</em>, which is derived from a Greek word that means sweet wood, comes from the inner bark of tropical evergreen cinnamon trees [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]. <em>Cinnamomum</em> (cinnamon) is a genus of the Lauraceae family, many of whose members are used as spices [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704529">2</a>]. It is one of the most widely used flavouring agents used in the food and beverage industry worldwide and well recognized for its medicinal properties since antiquity. Traditional Ayurvedic medicine has used cinnamon extracts for ailments such as arthritis, diarrhoea and menstrual irregularities [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704516">3</a>].</p><p id="__p7">To date, about 250 species of cinnamon has been identified, 4 of which are used to obtain the spice cinnamon. True or Ceylon Cinnamon (<em>Cinnamomum verum</em>) (syn <em>C. zeylanicum</em>) is a small evergreen tree native to Sri Lanka. Chinese cassia cinnamon (<em>Cinnamomum cassia</em>) is the other most widely available species [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704442">4</a>].</p><p id="__p8">Preparation of cinnamon involves stripping of the outer bark of the tree and letting the inner bark to dry and curl up into its customary cinnamon quills. Cinnamon is available in either its whole quill form (Cinnamon sticks) or as ground powder in the market [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704476">5</a>].</p><p id="__p9">At present Cinnamon is sold as both a preventative and therapeutic supplement for many ailments including, metabolic syndrome, insulin resistance, type 2 diabetes, hyperlipidaemia and arthritis [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704551">5</a>].</p><p id="__p10" class="p p-last">Cinnamon is known to have anti-diabetic properties, in addition to which, it is also perceived to have anti-oxidant, anti-inflammatory and anti-bacterial properties [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704478">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704494">7</a>].</p></div><div id="Sec3" class="sec"><h3>Burden of diabetes and use of complementary medicines</h3><p id="__p11" class="p p-first">Increasing prevalence of diabetes mellitus is a major cause of morbidity and mortality worldwide. The WHO estimates a prevalence of 347 million people with diabetes worldwide in 2015 [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>]. Diabetes mellitus is an illness, where a wide array of complementary and alternative medicines (CAMs) has been used with varying success. Around 2-3.6 million people in the United States rely on complementary and alternative medicines for the treatment of their diabetes mellitus [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704530">9</a>].</p><p id="__p12">Studies have been consistent in showing that diabetic patient adherence to current conventional treatment protocols are poor [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704535">10</a>]. Diabetic patients are 1.6 times more likely than non-diabetics to use a CAM for a host of reasons [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704564">11</a>].</p><p id="__p13">Complex treatment regimes, hypoglycaemia, patient beliefs and side effects of medications have been compelling reasons that limited patient compliance with conventional treatment [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704499">9</a>].</p><p id="__p14">The worldwide trend for the use of CAMs in diabetes has increased with an overall prevalence ranging between 30-57&#x000a0;% [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704515">12</a>].</p><p id="__p15">Recent estimates show that over 80&#x000a0;% of people living in developing countries depend on CAM for treatment of health conditions [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704554">9</a>]. In the United States an increase of 380&#x000a0;% is seen in the use of herbal remedies [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704540">13</a>]. The economic burden of CAMs is substantial, with the UK population in 2001 having spent an estimated 340 million pounds on CAMs [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704508">14</a>]. More recently in 2013, Herman estimates the cost of Complementary and Integrative Medicine (CIM) in the US to be 34 billion dollars [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704533">15</a>].</p><p id="__p16">Integrative medicine is a new discipline of medicine that combines conventional medicine with evidence-based complementary medicines. Patients with diabetes are increasingly eager to be part of their disease management and keen to try out integrative strategies that involve lifestyle changes and self management [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704480">16</a>].</p><p id="__p17" class="p p-last">Therefore it is timely to review the evidence that supports its use at both molecular and clinical levels.</p></div><div id="Sec4" class="sec"><h3>Pathogenesis of Type 2 diabetes and insulin resistance</h3><p id="__p18" class="p p-first">Type 2 diabetes is a complex metabolic disorder of insulin sensitivity and action on peripheral tissues like skeletal muscle and adipose tissue and of impaired insulin secretion.</p><p id="__p19">Insulin signaling involves a cascade of events initiated by insulin binding to its cell surface receptor. The receptor consists of 2 &#x003b1; and 2 &#x003b2; subunits that is disulfide linked into a hetero-tetrameric complex. Insulin binds to the extracellular &#x003b1;&#x000a0;subunits, activating the intra cellular tyrosine kinase domain of the &#x003b2;&#x000a0;subunit. This is followed by receptor autophosphorylation, and activation of receptor tyrosine kinases, which result in tyrosine phosphorylation of insulin receptor substrates (IRSs) including IRS1, IRS2, IRS3, IRS4, Gab1, and Shc [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704521">17</a>].</p><p id="__p20">The &#x003b2;&#x000a0;subunit is known to undergo serine/threonine phosphorylation, which decreases its ability to autophosphorylate to initiate the phosphorylation of the IRSs in insulin resistant animal models and humans. The activation of AMP activated protein kinase (AMPK) induces the translocation of glucose transporter 4 (GLUT4) to the plasma membrane [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921179">18</a>], and several studies have demonstrated that AMPK and its signaling pathway are potential molecular targets in the development of drugs for the treatment of type 2 diabetes and obesity [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921169">19</a>].</p><p id="__p21">IRSs also leads to translocation of insulin mediated GLUT-4 from intracellular vesicles to the plasma membrane, facilitating glucose entry. In the same process, the insulin receptor is dephosphorylated and inactivated. This internalization and the dephosphorylation of the insulin receptor are done by the protein tyrosine phosphatases. Therefore the physiological action of insulin is a delicate balance between phosphorylation and dephsophorylation. Phosphatidylinositol 3-kinase (PI3K) is a key component of the insulin-signaling cascade, essential for the metabolic effects of insulin on glucose transport and GLUT4 translocation [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704510">17</a>].</p><p id="__p22" class="p p-last">Derangement of insulin signaling pathways such as the impaired activation of the phosphatidylinositol 3-kinase and downstream signaling is thought to be responsible for the onset of insulin resistance and diabetes.</p></div><div id="Sec5" class="sec"><h3>Chemical composition, active constituents and metabolism</h3><p id="__p23" class="p p-first">A plant is made up of many thousands of bioactive compounds and isolation of such compounds can be tedious and time consuming.</p><p id="__p24">Jayaprakasha et al in 2011, using hydro-distillation techniques attempted to isolate the volatile oils of Cinnamon contained in the leaves and the bark. The major compounds were found to be Eugenol, cinnamaldehyde, copane, cinnamyl acetate and camphor, along with minor constituents [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704506">4</a>]. Previous investigators had isolated Cinnamaldehyde, cinnamyl acetate and camphor from the bark. The active compound of Cinnamon with hypoglycaemic activity is a contentious issue [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>]. To date, multiple compounds with hypoglycaemic properties have been isolated and used in both animal and clinical trials. A few such compounds are briefly discussed.</p><p id="__p25">Babu et al used cinnamaldehyde extracted from <em>Cinnamomum zeylanicum</em> to demonstrate a significant reduction of plasma glucose and HbA1c levels in streptozotcin induced diabetic rats [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921180">21</a>]. This study was carried out to isolate and identify the putative anti-diabetic compounds based on bioassay-guided fractionation. Cinnamaldehyde thus isolated was orally fed to diabetic rats, which caused significant reduction of plasma glucose and increased insulin levels. The authors concluded that cinnamaldehyde is responsible for increasing insulin secretion from pancreatic &#x003b2; cells and thus ameliorating glucose levels [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921164">21</a>].</p><p id="__p26">The stem of <em>cinnamomum cassia</em> (Cinnamoni ramulus) has been used in rats to determine its pharmacokinetic properties. The essential oil of cinnamoni ramulus is made up of a large number of aromatic compounds, which include cinnamaldehyde, cinnamic acid and 2-methoxy cinnamic acid. Bin Ji and colleagues demonstrated that following the oral administration of 15&#x000a0;mg cinnamon oil, the C<sub>max</sub> and the AUC for 2-methoxy cinnamic acid (0.01&#x000a0;% in essential oil of cinnamon ramulus) were greater than those of cinnamaldehyde (83.49&#x000a0;% in essential oil of cinnamoni ramulus) implying that the active metabolite of the essential oil might be 2-methoxy cinnamic acid [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704561">22</a>]. Chen demonstrated that the bioavailability of cinnamic acid was higher when cinnamoni ramulus was fed to rats in contrast to when pure cinnamic acid was fed. Pure cinnamic acid was quickly transformed into hippuric acid. Cinnamldehyde in the cinnamoni ramulus is metabolized into cinnamic acid in the liver [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704519">23</a>].</p><p id="__p27">In another study, Anderson et al demonstrated the active ingredient responsible for the anti-diabetic effect of Cinnamon is probably a water soluble constituent. In this study, specimens from C. cassia, C. verum, C, burmanni and C. loureinii were tested. Insulin enhancing biological activity of cinnamon was measured using epididymal fat cell assay. Adipocytes and glucose were incubated in the presence of insulin and or insulin and aqueous extract of cinnamon.</p><p id="__p28">Water-soluble polyphenol polymers from cinnamon, that increase insulin-dependent in vitro glucose metabolism roughly 20-fold and display antioxidant activity were isolated by them and was characterized by nuclear magnetic resonance and mass spectroscopy. The polymers were composed of monomeric units with a molecular mass of 288 [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704525">24</a>]. These compounds have been identified as trimers and tetramers of the flavonoids, catechin and epicatechin. These cinnamon polyphenols (CP) with doubly linked procyanidin type-A polymers appear to be unique for their insulin-like activity, because other cinnamon compounds display little or no such activity [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704448">24</a>].</p><p id="__p29">The other compounds of cinnamon that showed little or no insulin like activity included; cinnamic acid, cinnamide, cinnamyl alcohol, eugenol and 2-methoxy-cinnamaldehyde under the assay conditions of this study. There was no difference in the insulin like activity between the different species tested.</p><p id="__p30" class="p p-last">The available evidence regarding the active compound(s) of cinnamon remains inconclusive. Multiple active compounds at different levels in the insulin signaling pathway is probably a safe intermediary interpretation until more robust evidence emerge.</p></div><div id="Sec6" class="sec"><h3>Potential mechanisms of action</h3><p id="__p31" class="p p-first">The mechanism by which cinnamon exerts its anti-diabetic activity is debated and is probably the result of its action at different levels of the insulin-signaling pathway.</p><div id="Sec7" class="sec"><h4>Insulin receptor</h4><p id="__p32" class="p p-first">The cellular response to insulin is mediated through the insulin receptor, which is a tetrameric protein consisting of two identical extracellular &#x003b1;-subunits that bind insulin as well as two identical transmembrane &#x003b2;-subunits that have intracellular tyrosine kinase activity [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921182">25</a>]. When insulin binds to the &#x003b1;-subunit of the receptor, the &#x003b2;-subunit tyrosine kinase is activated, resulting in autophosphorylation of &#x003b2;-subunit tyrosine residues [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921159">26</a>].</p><p id="__p33" class="p p-last">Increased autophosphorlylation and decreased dephosphorylation [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704467">27</a>] of the insulin receptor is one mechanism that increases the insulin sensitivity. Cinnamtannin B1, a proanthocyanidin isolated from the stem bark of Ceylon cinnamon, activates the phosphorylation of the insulin receptor &#x003b2;-subunit on adipocytes as well as other insulin receptors [<a href="#CR28" rid="CR28" class=" bibr popnode">28</a>].</p></div><div id="Sec8" class="sec"><h4>Glucose transporter 4 (GLUT 4)</h4><p id="__p34" class="p p-first">GLUT4 is the major glucose transporter in skeletal muscle and adipose tissue, which is under control of insulin. It is well established that insulin promotes the translocation of GLUT-4 from the intracellular compartment to the cell membrane [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704452">29</a>]. In diabetes mellitus because of the absence or insufficient sensitivity to insulin, GLUT 4, is decreased. Nikzamir and colleagues reported a significant increase in the expression of GLUT 4 receptor and its mRNA, in cinnamaldehyde treated C2C12 skeletal muscle cells using Real Time PCR [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921163">30</a>].</p><p id="__p35">Recently Shen et al reported that cinnamon extract ameliorates type 2 diabetes by inducing GLUT4 translocation <em>via</em> the AMPK signaling pathway. The activation of AMPK induces the translocation of GLUT4 to the plasma membrane, and several studies have demonstrated that AMPK and its signaling pathway are potential molecular targets in the development of drugs for the treatment of type 2 diabetes and obesity [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921181">19</a>].</p><p id="__p36">Cinnamon increases the amount of GLUT4 receptors as well as Insulin Receptor (IR) and Insulin Receptor substrates [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921174">19</a>, <a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704567">31</a>, <a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704450">32</a>], thereby facilitating glucose entry into cells.</p><p id="__p37" class="p p-last">Shen et al demonstrated that extracts of <em>Cinnamomum zeylanicum</em> increased the production and translocation to the plasma membrane of the GLUT 4 in brown adipose tissue and muscle in a dose dependent manner [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921162">33</a>]. Anand et al demonstrated a similar finding but quantified the effect by demonstrating an increase of the membrane translocation of GLUT4 from 42.8&#x000a0;% to 73.1&#x000a0;% in cinnamon treated rats when compared to healthy controls [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921186">34</a>].</p></div><div id="Sec9" class="sec"><h4>Glucose transporter-1 (GLUT 1)</h4><p id="__p38" class="p p-first-last">Glucose transporter-1 (GLUT-1) is a receptor expressed on mammalian cells that is responsible for basal glucose uptake into cells. The exact mechanism of activation of this receptor is poorly understood [<a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704563">35</a>]. L 929 fibroblasts are totally dependent on GLUT-1 receptors for glucose uptake into cells [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921185">36</a>]. Plaisier and colleagues demonstrated cinnamldehyde increases the GLUT 1 mediated glucose uptake in a dose dependent manner in the L 929 fibroblasts. However in the presence of glucose deprivation in the medium, cinnamldehyde reduced the GLUT 1 mediated glucose uptake [<a href="#CR37" rid="CR37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704470">37</a>].</p></div><div id="Sec10" class="sec sec-last"><h4>Glucagon-like peptide-1 (GLP-1)</h4><p id="__p39" class="p p-first-last">Plexopathy demonstrated a dose dependent reduction of serum insulin concentrations and an increase in glucagon-like peptide 1(GLP-1) with cinnamon treatment [<a href="#CR38" rid="CR38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704454">38</a>]. Similarly Hlebowicz et al in 2009 reported that the addition of 3&#x000a0;g of cinnamon to a rice meal caused significant increase of GLP-1 levels with decreased serum insulin [<a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704517">39</a>]. Improved glucose transport across the cell membrane reduces the insulin resistance and this probably accounts for the reduced insulin levels.</p></div></div><div id="Sec11" class="sec"><h3>Peroxisome proliferator activator receptor (PPAR)</h3><p id="__p40" class="p p-first">Peroxisome proliferator-activated receptor gamma (PPAR-&#x003b3; or PPARG), is a type II <a href="http://en.wikipedia.org/wiki/Nuclear_receptor" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">nuclear receptor</a> that, in humans is encoded by the PPARG <a href="http://en.wikipedia.org/wiki/Gene" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">gene</a>. This gene encodes a member of the <a href="http://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">peroxisome proliferator-activated receptor</a> (PPAR) subfamily of nuclear receptors [<a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704552">40</a>]. PPARs form heterodimers with <a href="http://en.wikipedia.org/wiki/Retinoid_X_receptor" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">retinoid X receptors</a> (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: <a href="http://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor_alpha" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">PPAR-&#x003b1;</a>, <a href="http://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor_delta" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">PPAR-&#x003b4;</a>, and PPAR-&#x003b3;. The protein encoded by this gene is PPAR-&#x003b3; and is a regulator of <a href="http://en.wikipedia.org/wiki/Adipocyte" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">adipocyte</a> differentiation. Activation of PPAR lowers plasma triglycerides and elevates plasma HDL cholesterol levels [<a href="#CR41" rid="CR41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921166">41</a>], at the same time increasing insulin sensitivity leading to its anti-diabetic effects [<a href="#CR42" rid="CR42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704500">42</a>]. PPAR agonists such as Pioglitazone are currently being used as potent anti-diabetic agents in conventional medicine [<a href="#CR43" rid="CR43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704507">43</a>].</p><p id="__p41" class="p p-last">Cinnamon causes an increase in the expression of PPAR (&#x003b1;) and PPAR (&#x003b3;), thereby increasing insulin sensitivity [<a href="#CR44" rid="CR44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704474">44</a>]. Sheng et al demonstrated that the water-soluble extract of Cinnamon has the ability to induce the expression of PPAR&#x003b1; and PPAR&#x003b3; both in vitro and in vivo in mouse adipose tissue. Further, treatment of mouse 3&#x000a0;T3-L1 pre-adipocytes with cinnamon extracts caused them to differentiate into adipocytes [<a href="#CR44" rid="CR44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704503">44</a>].</p></div><div id="Sec12" class="sec"><h3>&#x003b1; glucosidase activity</h3><p id="__p42" class="p p-first">Adisakwattana studied the inhibitory effects of 4 types of cinnamon on intestinal maltase and sucrase, pancreatic &#x003b1;-amylase, and their combined effect in the presence with acarbose [<a href="#CR45" rid="CR45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704457">45</a>].</p><p id="__p43">The HPLC fingerprints of each cinnamon species were established. Among cinnamon species, Thai cinnamon extract was the most potent inhibitor against the intestinal maltase.</p><p id="__p44">They also demonstrated that Ceylon cinnamon was most the potent inhibitor of pancreatic amylase and intestinal sucrase. However its potency to inhibit these 2 enzymes was less than that of acarbose [<a href="#CR45" rid="CR45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704438">45</a>]. However when used together with acarbose the cinnamon extracts produced an additive inhibitory effect against all 3 enzymes.</p><p id="__p45">Ranilla et al also demonstrated that Ceylon cinnamon possessed a high dose dependent inhibition of alpha glucosidase and pancreatic alpha amylase [<a href="#CR46" rid="CR46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704439">46</a>].</p><p id="__p46" class="p p-last">These results suggest that cinnamon bark extracts may be potentially useful for the control of postprandial glucose in diabetic patients through inhibition of intestinal &#x003b1;-glucosidase and pancreatic &#x003b1;-amylase.</p></div><div id="Sec13" class="sec"><h3>Effects on gluconeogenesis</h3><p id="__p47" class="p p-first-last">Pyruvate kinase (PK) and Phosphenol Pyruvate Carboxikinase (PEPCK) are 2 key enzymes regulating the hepatic glucose metabolism. In diabetic rats the PK activity is reduced and PEPCK activity is elevated. The reduced PK activity of Streptozotocin treated rats is restored to near normal values upon treatment with cinnamon. This effect is also observed when diabetic animals are treated with Glibenclamide as well, but the response is less compared to cinnamon [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921178">34</a>]. Similarly, significantly elevated PEPCK activity of Streptozotocin induced diabetic rats again nearly normalizes albeit at a slightly higher value than normal values on treatment with cinnamon [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921167">34</a>]. The net result is a stimulation of Glycogen synthesis and inhibition of gluconeogenesis, improving glucose metabolism (Fig.&#x000a0;<a href="/pmc/articles/PMC4609100/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC4609100/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140320725345680" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12937_2015_98_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12937_2015_98_Fig1_HTML.jpg" src="/pmc/articles/PMC4609100/bin/12937_2015_98_Fig1_HTML.jpg" /></div><div id="largeobj_idm140320725345680" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4609100/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC4609100/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><p id="__p48">Molecular mechanisms of Cinnamon by which it exerts hypoglycaemic activity. PK: Pyruvate Kinase, PEPCK: Phosphoenol Carboxy Kinase, PPAR-gamma: Peroxisome Proloferator Activated-Receptor gamma, WAT: White Adipose Tissue, ACO: Acyl-CoA Oxidase, GLUT-4: Glucose transporting protein 4, LPL: Lipoprotein lipase, CD36:Fatty Acid Transporter</p></div></div></div></div><div id="Sec14" class="sec"><h3>Gastric emptying</h3><p id="__p49" class="p p-first-last">Hlebowicz et al studied the effect of cinnamon on Gastric Emptying Rate (GER) of 14 healthy adults. The GER was measured by using standardized real-time ultrasonography. The subjects were examined after an 8-hour fast if they had normal fasting plasma glucose (FPG) concentrations. The subjects were given 300&#x000a0;g of rice pudding with or without the addition of 6&#x000a0;g of cinnamon. Addition of cinnamon delayed the gastric emptying but caused a more pronounced reduction in post prandial blood glucose and did not affect satiety [<a href="#CR47" rid="CR47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921170">47</a>]. However the addition of either 1 or 3&#x000a0;g of cinnamon to a rice meal did not have any effect on the GER or the glucose levels [<a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704473">39</a>].</p></div><div id="Sec15" class="sec"><h3>Efficacy in animal studies</h3><p id="__p50" class="p p-first">Ranasinghe et al performed a meta-analysis of studies utilizing <em>Cinnamon zeylanicum</em>. In vivo studies utilizing diabetic rats were included, and they analyzed the effect of cinnamon on weight, (FPG), total cholesterol, HDL-cholesterol, triglycerides and serum insulin. Cinnamon was able to check the weight loss of diabetic rats. It also improved the FPG [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704565">9</a>].</p><p id="__p51">The result for total cholesterol was conflicting with some trials showing an increase in cholesterol with cinnamon [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921160">33</a>, <a href="#CR48" rid="CR48" class=" bibr popnode">48</a>] while others showed a reduction [<a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704511">49</a>]. HDL-cholesterol showed an increase with cinnamon treatment [<a href="#CR48" rid="CR48" class=" bibr popnode">48</a>, <a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704456">49</a>]. Triglyceride levels also showed a distinct reduction in comparison to controls [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704528">9</a>].</p><p id="__p52">Anand et al. demonstrated that the HbA1c of diabetic rats treated with cinnamon and Glibenclamide was less than that of untreated control diabetic rats [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921184">34</a>]. Subash Babu demonstrated an HbA1C reduction of 40.2&#x000a0;% in cinnamon treated rats compared to untreated diabetic rats [<a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704479">49</a>]. However, Ranasinghe et al failed to demonstrate a significant fall of HbA1c in cinnamon treated diabetic rats after 30&#x000a0;days treatment, although significant reduction was observed in fasting and postprandial glucose [<a href="#CR50" rid="CR50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704520">50</a>]. The failure to demonstrate an improvement in HbA1C may be due to the short duration of 30&#x000a0;days, of this trial.</p><p id="__p53">Kannappan et al. [<a href="#CR51" rid="CR51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921171">51</a>] demonstrated the ability of cinnamon to reduce the blood glucose of high fructose diet fed rats. The mean FPG of high-fructose fed rats was high compared to control rats. Treatment with cinnamon caused significant decrease of FPG in the high-fructose fed rats compared to high fructose fed untreated rats. The high fructose fed rats had high serum insulin levels and HbA1c. Upon treatment with cinnamon there was significant decrease of both serum insulin and HbA1c. Additionally the elevated total plasma cholesterol, triglycerides and free fatty acids in the high fructose fed rats normalized following administration of cinnamon.</p><p id="__p54">Shihabudeen et al. studied the effect of cinnamon on post-prandial blood glucose of maltose and sucrose loaded Streptozotocin induced diabetic rats. Cinnamon caused a 65.1&#x000a0;% reduction in the glycaemic response of normal rats following maltose loading. In diabetic rats compared to controls, there was a 78.2&#x000a0;%, 86.3&#x000a0;% and 54.2&#x000a0;% reduction in the glycaemic response when treated with escalating doses of cinnamon of 300&#x000a0;mg/kg, 600&#x000a0;mg/Kg and 5&#x000a0;mg/Kg of Acarbose respectively. There was a similar response with sucrose loading. However the study failed to show a reduction in glycaemic response in glucose treated healthy and diabetic rats treated with cinnamon [<a href="#CR52" rid="CR52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704443">52</a>].</p><p id="__p55" class="p p-last">Shalaby et al. studied the effect of cinnamon on alloxan induced obese diabetic Sprague Dawley rats. The test animals were initially fed a high fat diet and then injected with alloxan to make them diabetic. Cinnamon administration caused significant reductions in weight, glucose, and lipid levels and normalized elevated liver enzymes while increasing the insulin levels [<a href="#CR53" rid="CR53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921168">53</a>].</p></div><div id="Sec16" class="sec"><h3>Efficacy in human studies</h3><p id="__p56" class="p p-first">To date, several randomized controlled studies exist that studied the effect of cinnamon on type 2 adult diabetic patients. These studies variably studied the effect of cinnamon on glycosylated haemoglobin, FPG, total cholesterol, LDL cholesterol and triglycerides [<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704447">54</a>&#x02013;<a href="#CR61" rid="CR61" class=" bibr popnode">61</a>].</p><p id="__p57">Seven trials used <em>Cinnamomum Cassia, Cinnamomum aromaticum</em> or <em>cinnamomum burmanii</em>. 1 trial did not specify the type of cinnamon used [<a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704549">57</a>]. None of the trails used <em>Cinnamomum zeylanicum.</em></p><p id="__p58">The duration of these interventions ranged from 40&#x000a0;days to 4&#x000a0;months, the patient numbers varied from 25 to 137 in each trial and the amount of cinnamon administered per day varied from 500&#x000a0;mg to 6&#x000a0;g.</p><p id="__p59">Of these studies, 2 showed no significant reduction in glucose values [<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704444">55</a>, <a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704455">56</a>], while 5 others showed reductions in FPG levels and or glycosylated haemoglobin [<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704489">54</a>, <a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704566">57</a>&#x02013;<a href="#CR60" rid="CR60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704477">60</a>].</p><p id="__p60">Khan et al. in 2003 studied a total of 60 patients, who were randomized to receive 1,3, or 6&#x000a0;g of cinnamon daily or a placebo. The background medication consisted of sulphonyureas only. At the end of 40&#x000a0;days, all 3 doses of cinnamon caused a significant decrease in FPG (18-29&#x000a0;%), total cholesterol (12-26&#x000a0;%), triglycerides (23-30&#x000a0;%) and LDL cholesterol (7-27&#x000a0;%) [<a href="#CR58" rid="CR58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704491">58</a>]. The change in HDL cholesterol was not significant. This study did not evaluate the effect of the intervention on HbA1c.</p><p id="__p61">Mang et al. randomized 79 type 2 adult diabetes patients on oral hypoglycaemic treatment or diet to receive either 3&#x000a0;g of cinnamon aqueous extract per day or placebo, in a randomized double blind clinical trial of 4&#x000a0;months duration. The study demonstrated a significant decrease of 10.3&#x000a0;% of the initial FPG values. However, the trial failed to demonstrate a significant lowering of HbA1c or plasma lipids [<a href="#CR59" rid="CR59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704440">59</a>]. The decrease in plasma FPG correlated significantly with the initial baseline concentrations indicating that patients with a higher initial glucose may benefit more from the addition of cinnamon.</p><p id="__p62">Crawford studied the administration of 1&#x000a0;g of cinnamon as an-add on to usual care of diabetes in 109 type 2 diabetic patients. Participants were randomly allocated to either usual care with management changes by their primary care physician or to usual care with management changes plus 1&#x000a0;g cinnamon capsules daily for 90&#x000a0;days. HbA1c was drawn at baseline and at 90&#x000a0;days and compared with intention-to-treat analysis. Patients receiving cinnamon had a significant reduction of their HbA1c by 0.83&#x000a0;% as opposed to 0.37&#x000a0;% reduction in patients receiving usual care alone [<a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704462">57</a>].</p><p id="__p63">Akilen et al in a randomized, placebo-controlled double blind clinical trial studied the effect of Cinnamon on 58, type 2 adult diabetic patients on oral hypoglycaemics by administering 2&#x000a0;g of cinnamon or placebo daily over a period of 12&#x000a0;weeks. The patients had an HbA1c greater than 7&#x000a0;% at recruitment. The results demonstrated a significant reduction in the HbA1c from 8.22&#x000a0;% to 7.86&#x000a0;% in the treatment group. The study also demonstrated a significant reduction in blood pressure, FPG, body mass index (BMI) and waist circumference at 12&#x000a0;weeks of treatment [<a href="#CR60" rid="CR60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704544">60</a>].</p><p id="__p64">Suppapitiporn studied the effect of cinnamon cassia powder in 60 type 2 diabetic patients on oral therapy consisting of Metformin or sulphonylurea in a randomized, placebo-controlled single blind clinical trial. After a 12-week period, HbA1c had decreased from 8.14&#x000a0;% to 7.76&#x000a0;% in the cinnamon group and from 8.06&#x000a0;% to 7.87&#x000a0;% in the placebo group. However the proportion of patients achieving HbA1c&#x02009;&#x0003c;&#x02009;or&#x02009;=&#x02009;7&#x000a0;% was greater in patients receiving Cinnamon, compared to patients receiving placebo. Nevertheless, it was not found to be statistically significant [<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704437">54</a>].</p><p id="__p65">More recently, Anderson et al in a RCT randomized 137 diabetic individuals to receive a commercial preparation of cinnamon (CinSulin 500&#x000a0;mg/day) or placebo for 2&#x000a0;months. CinSulin constituted a spray-dried water extract of cinnamon. The study measured the FPG, 2-hr glucose and the insulin resistance (using the HOMA-IR). Additional measurements included the systolic and diastolic blood pressures, serum lipids and fructosamine levels. At the end of 2&#x000a0;months the authors demonstrated a significant decrease of both FPG (In the cinnamon treated group; 8.85&#x02009;&#x000b1;&#x02009;0.36 to 8.19&#x02009;&#x000b1;&#x02009;0.29&#x000a0;mmol/L (<em>p</em>&#x02009;&#x0003c;&#x02009;0.005), compared with 8.57&#x02009;&#x000b1;&#x02009;0.32 to 8.44&#x02009;&#x000b1;&#x02009;0.34&#x000a0;mmol/L in the placebo control group (<em>p</em> 1&#x02044;4 0.45), 2-hr glucose values following 75&#x000a0;g glucose load (in the cinnamon extract-supplemented group, 15.09&#x02009;&#x000b1;&#x02009;0.57 to 13.3&#x02009;&#x000b1;&#x02009;0.55&#x000a0;mmol/L (<em>P</em>&#x02009;&#x0003c;&#x02009;0.001), compared with non-significant differences in the placebo group, 14.18&#x02009;&#x000b1;&#x02009;0.60 to 13.74&#x02009;&#x000b1;&#x02009;0.58&#x000a0;mmol/L). Insulin sensitivity, assessed by HOMA-IR, was also significantly improved by cinnamon extract as were fructosamine concentrations [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>].</p><p id="__p66">Vanschoonbeek et al studied the effect of 1.5&#x000a0;g of cinnamon per day on insulin sensitivity/glucose tolerance and blood lipids on 25 Type 2 post-menopausal women on oral hypoglycaemic medications over a period of 6&#x000a0;weeks in a placebo controlled study. They demonstrated that cinnamon made no significant improvement in either blood glucose or lipids at the end of the study period [<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704558">55</a>].</p><p id="__p67">Blevins et al studied the effect of 1&#x000a0;g of cinnamon cassia on blood glucose and lipids in 60 type 2 diabetic subjects in a placebo-controlled study over a 3-month duration. The trial did not show a significant improvement in either blood glucose or lipids at the end of the study [<a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704463">56</a>].</p><p id="__p68">In a systematic review and meta analysis published in 2012, Akilen et al reviewed 6 RCTs (<em>n</em>&#x02009;=&#x02009;435 patients) that studied the glycaemic outcomes of cinnamon in type 2 diabetes. The meta analysis of RCTs showed, a significant decrease in mean HbA1c (0.09&#x000a0;%; 95&#x000a0;% CI was 0.04-0.14) and FPG (0.84&#x000a0;mmol/L; 95&#x000a0;% CI was 0.66-1.02) [<a href="#CR62" rid="CR62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704496">62</a>].</p><p id="__p69">Allen et al performed another systematic review and meta analysis of 10 RCTs (<em>n</em>&#x02009;=&#x02009;543 patients) published up to 2012. They demonstrated that cinnamon significantly reduced FPG (-24.59&#x000a0;mg/dl; 95&#x000a0;% -40.52 to -8.67&#x000a0;mg/dl), but not HbA1c levels (-0.16&#x000a0;%; CI -0.39&#x000a0;% to 0.02&#x000a0;%) [<a href="#CR63" rid="CR63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704459">63</a>].</p><p id="__p70">A Cochrane review published in 2012 analyzed 10 clinical trials involving 577 patients with either type 1 or type 2 diabetes. The trials used <em>Cinnamomum cassia</em> at a mean dose of 2&#x000a0;g per day over a period of 4-16 weeks. The authors concluded that the effect of cinnamon on FPG was inconclusive and there was no significant reduction of HbA1c or post prandial glucose [<a href="#CR64" rid="CR64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704468">64</a>].</p><p id="__p71">Ranasinghe et al performed a systematic review and meta analysis of 16 studies that specifically utilized Ceylon cinnamon. However, there were no human trials that utilized Ceylon cinnamon. In animal studies it caused significant reductions of FPG and HbA1c [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704446">9</a>].</p><p id="__p72" class="p p-last">A summary of the clinical trials is given below (Table&#x000a0;<a href="/pmc/articles/PMC4609100/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p73">Summary of clinical trials using cinnamon and their outcomes</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140320721457360" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="2"></th><th rowspan="2" colspan="1">Study design</th><th rowspan="2" colspan="1">Duration</th><th colspan="2" rowspan="1">Type of cinnamon &#x00026; dose/day</th><th colspan="2" rowspan="1">FPG</th><th colspan="2" rowspan="1">HbA<sub>1</sub>C</th></tr><tr><th colspan="2" rowspan="1"></th><th rowspan="1" colspan="1">Baseline mean&#x02009;&#x000b1;&#x02009;SD</th><th rowspan="1" colspan="1">Post intervention mean&#x02009;&#x000b1;&#x02009;SD</th><th rowspan="1" colspan="1">Baseline Mean&#x02009;&#x000b1;&#x02009;SD</th><th rowspan="1" colspan="1">Post intervention&#x02009;&#x000b1;&#x02009;SD</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">1</td><td rowspan="2" colspan="1">Khan et al [<a href="#CR58" rid="CR58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704458">58</a>]</td><td rowspan="2" colspan="1">Single-blind RCT</td><td rowspan="2" colspan="1">40&#x000a0;days intervention 20&#x000a0;days washout</td><td rowspan="2" colspan="1"><em>C.cassia</em> powder 1&#x000a0;g,3&#x000a0;g,6&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">13.77&#x02009;&#x000b1;&#x02009;1.33</td><td rowspan="1" colspan="1">13.97&#x02009;&#x000b1;&#x02009;1.23</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">12.0&#x02009;&#x000b1;&#x02009;1.43</td><td rowspan="1" colspan="1">9.1&#x02009;&#x000b1;&#x02009;1.40</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td></tr><tr><td rowspan="2" colspan="1">2</td><td rowspan="2" colspan="1">Mang et al [<a href="#CR72" rid="CR72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704553">72</a>]</td><td rowspan="2" colspan="1">Double- blind RCT</td><td rowspan="2" colspan="1">40&#x000a0;days</td><td rowspan="2" colspan="1"><em>C.cassia</em> aqueous extract 3&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">8.66&#x02009;&#x000b1;&#x02009;1.47</td><td rowspan="1" colspan="1">8.31&#x02009;&#x000b1;&#x02009;1.62</td><td rowspan="1" colspan="1">6.71&#x02009;&#x000b1;&#x02009;0.73</td><td rowspan="1" colspan="1">6.68&#x02009;&#x000b1;&#x02009;0.7</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">9.26&#x02009;&#x000b1;&#x02009;2.26</td><td rowspan="1" colspan="1">8.15&#x02009;&#x000b1;&#x02009;1.65</td><td rowspan="1" colspan="1">6.86&#x02009;&#x000b1;&#x02009;1.00</td><td rowspan="1" colspan="1">6.83&#x02009;&#x000b1;&#x02009;0.83</td></tr><tr><td rowspan="2" colspan="1">3</td><td rowspan="2" colspan="1">Suppapitiporn et al [<a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704524">54</a>]</td><td rowspan="2" colspan="1">Single blind RCT</td><td rowspan="2" colspan="1">12&#x000a0;weeks</td><td rowspan="2" colspan="1">C.cassia powder 1.5&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">8.14</td><td rowspan="1" colspan="1">7.76</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">8.06</td><td rowspan="1" colspan="1">7.87</td></tr><tr><td rowspan="2" colspan="1">4</td><td rowspan="2" colspan="1">Vanschoonbe et al [<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704509">55</a>]</td><td rowspan="2" colspan="1">Double-blind RCT</td><td rowspan="2" colspan="1">6&#x000a0;weeks</td><td rowspan="2" colspan="1"><em>C.cassia</em> powder 1.5&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">8.28&#x02009;&#x000b1;&#x02009;0.33</td><td rowspan="1" colspan="1">8.07&#x02009;&#x000b1;&#x02009;0.36</td><td rowspan="1" colspan="1">7.1&#x02009;&#x000b1;&#x02009;0.2</td><td rowspan="1" colspan="1">7.2&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">8.37&#x02009;&#x000b1;&#x02009;0.64</td><td rowspan="1" colspan="1">7.91&#x02009;&#x000b1;&#x02009;0.71</td><td rowspan="1" colspan="1">7.4&#x02009;&#x000b1;&#x02009;0.3</td><td rowspan="1" colspan="1">7.5&#x02009;&#x000b1;&#x02009;0.3</td></tr><tr><td rowspan="2" colspan="1">5</td><td rowspan="2" colspan="1">Blevins et al [<a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704495">56</a>]</td><td rowspan="2" colspan="1">Double-blind RCT</td><td rowspan="2" colspan="1">3&#x000a0;months</td><td rowspan="2" colspan="1"><em>C.cassia</em> powder 1&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">8.04</td><td rowspan="1" colspan="1">8.02</td><td rowspan="1" colspan="1">7.1</td><td rowspan="1" colspan="1">7.2</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">7.38</td><td rowspan="1" colspan="1">6.84</td><td rowspan="1" colspan="1">7.2</td><td rowspan="1" colspan="1">7.4</td></tr><tr><td rowspan="2" colspan="1">6</td><td rowspan="2" colspan="1">Crawford [<a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704518">57</a>]</td><td rowspan="2" colspan="1">Randomized placebo controlled trial (no blind/open)</td><td rowspan="2" colspan="1">90&#x000a0;days</td><td rowspan="2" colspan="1"><em>C.cassia</em> powder 1&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">8.28&#x02009;&#x000b1;&#x02009;1.3</td><td rowspan="1" colspan="1">7.91&#x02009;&#x000b1;&#x02009;1.5</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">8.47&#x02009;&#x000b1;&#x02009;1.8</td><td rowspan="1" colspan="1">7.64&#x02009;&#x000b1;&#x02009;1.7</td></tr><tr><td rowspan="2" colspan="1">7</td><td rowspan="2" colspan="1">Akilen et al [<a href="#CR60" rid="CR60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704531">60</a>]</td><td rowspan="2" colspan="1">Double-blind RCT</td><td rowspan="2" colspan="1">12&#x000a0;weeks</td><td rowspan="2" colspan="1"><em>C.cassia</em> powder 2&#x000a0;g</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">8.77&#x02009;&#x000b1;&#x02009;2.59</td><td rowspan="1" colspan="1">8.74&#x02009;&#x000b1;&#x02009;3.11</td><td rowspan="1" colspan="1">8.55&#x02009;&#x000b1;&#x02009;1.82</td><td rowspan="1" colspan="1">8.68&#x02009;&#x000b1;&#x02009;1.83</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">8.82&#x02009;&#x000b1;&#x02009;3.45</td><td rowspan="1" colspan="1">8.04&#x02009;&#x000b1;&#x02009;3.10</td><td rowspan="1" colspan="1">8.22&#x02009;&#x000b1;&#x02009;1.16</td><td rowspan="1" colspan="1">7.86&#x02009;&#x000b1;&#x02009;1.42</td></tr><tr><td rowspan="2" colspan="1">8</td><td rowspan="2" colspan="1">Anderson et al [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>]</td><td rowspan="2" colspan="1">Randomized placebo controlled trial</td><td rowspan="2" colspan="1">2&#x000a0;months</td><td rowspan="2" colspan="1">C.cassia(CinSulin) 500&#x000a0;mg</td><td rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">8.57&#x02009;&#x000b1;&#x02009;0.32</td><td rowspan="1" colspan="1">8.44&#x02009;&#x000b1;&#x02009;0.34</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td></tr><tr><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">8.85&#x02009;&#x000b1;&#x02009;0.36</td><td rowspan="1" colspan="1">8.19&#x02009;&#x000b1;&#x02009;0.29</td><td rowspan="1" colspan="1">_</td><td rowspan="1" colspan="1">_</td></tr></tbody></table></div><div id="largeobj_idm140320721457360" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4609100/table/Tab1/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec17" class="sec"><h3>Effecacy in pre-diabetes</h3><p id="__p74" class="p p-first">Roussel et al [<a href="#CR65" rid="CR65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704512">65</a>] in a double blind placebo-controlled study investigated the effect of dried aqueous extract of cinnamon on oxidative stress markers and the possible correlation with FPG and plasma insulin levels, in over weight and obese patients with impaired fasting glycaemia over a 12-week period. Twenty-two subjects with FPG in the range of 100-126&#x000a0;mg/dl were selected, and were either given a placebo or 500&#x000a0;mg/d of cinnamon over 12&#x000a0;weeks. In the cinnamon group the impaired fasting glucose levels were significantly reduced (114&#x02009;&#x000b1;&#x02009;2.2 to 102&#x02009;&#x000b1;&#x02009;4.3) at the end of 12&#x000a0;weeks. The reduction in fasting glucose was more pronounced at 12&#x000a0;weeks compared to 6&#x000a0;weeks of supplementation. Similarly, there was significant improvement in plasma oxidative stress markers. However, there was no increase in plasma insulin levels [<a href="#CR65" rid="CR65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704441">65</a>].</p><p id="__p75" class="p p-last">Similarly, Ziegenfuss in a randomized placebo-controlled double blind clinical trial studied the effect of &#x0201c; Cinnulin&#x0201d; 500&#x000a0;mg (500&#x000a0;mg of Cinnulin contains 10&#x000a0;g of whole cinnamon powder according to the manufacturer) per day on serum chemistry, body weight, and composition over a 12-week period on 22 adult subjects with the metabolic syndrome and pre-diabetes. At the end of 12&#x000a0;weeks, the subjects in the Cinnulin group had significant decrease of FPG (-8.4&#x000a0;%: from 116&#x02009;&#x000b1;&#x02009;12.8&#x000a0;mg/dl (pre) to 106.5&#x02009;&#x000b1;&#x02009;20.1&#x000a0;mg/dl (post), <em>P</em>&#x02009;&#x0003c;&#x02009;0.01) compared to subjects in the placebo group [<a href="#CR66" rid="CR66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704543">66</a>].</p></div><div id="Sec18" class="sec"><h3>Safety</h3><p id="__p76" class="p p-first">Anand et al studied the escalating doses of <em>Cinnamomum zeylanicum</em> (100&#x000a0;mg/Kg, 200&#x000a0;mg/Kg and 400&#x000a0;mg.Kg respectively), all exceeding therapeutic doses on healthy Wistar rats. They observed no behavioural changes in the animals. Alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, creatinine and total bilirubin values remained normal during the length of the study period [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921165">34</a>].</p><p id="__p77">However animals administered 20 times the effective dose of cinnamon showed a slight, insignificant rise in SGPT, SGOT and ALP, which normalized after 120&#x000a0;hours following administration [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921176">34</a>]. This dose is comparable to a human adult dose of 600-2400&#x000a0;mg/Kg.</p><p id="__p78">Subash et al demonstrated that significantly elevated ALP, SGOT and SGPT in streptozotocin induced diabetic rats near-normalized following the administration of Cinnamon [<a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704453">49</a>].</p><p id="__p79">Shen at al studied the effect of cinnamon at variable doses on the glycaemic effect and renal functions of Streptozotocin induced diabetic rats. Animals receiving cinnamon extract in doses exceeding 30&#x000a0;mg/Kg, demonstrated reduction in creatinine values [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921158">33</a>].</p><p id="__p80">However, Al-Logmani and Zari demonstrated a significant rise in uric acid and blood urea in streptozotocin induced diabetic rats when compared to controls [<a href="#CR67" rid="CR67" class=" bibr popnode">67</a>] upon administration of cinnamon.</p><p id="__p81">Thus in animals there is no significant toxicity of cinnamon on the liver, but the results relating to renal functions are controversial, raising the need for more studies to evaluate its effect on the kidney.</p><p id="__p82">A search of the literature for RCTS using human subjects did not reveal any reported significant adverse events when <em>Cinnamomum cassia</em> is used in doses of 500&#x000a0;mg-6&#x000a0;g per day. However there were four instances where patients reported rash, hives, nausea and one hypoglycaemic seizure [<a href="#CR64" rid="CR64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704526">64</a>].</p><p id="__p83">Although short-term trials have not demonstrated any significant adverse outcomes with cinnamon cassia use, its high coumarin content is a concern during prolonged use [<a href="#CR68" rid="CR68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704513">68</a>]. Coumarins are naturally occurring plant compounds with carcinogenic and hepatotoxic properties [<a href="#CR69" rid="CR69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704465">69</a>]. Cinnamon cassia which was used in all the human trials, has a higher coumarin content compared to true cinnamon (Ceylon or Sri Lankan Cinnamon) High Performance liquid Chromatography (HPLC) has been used to quantitatively analyze the content. Sproll and colleagues demonstrated the coumarin content of true cinnamon was undetectable while that of cassia cinnamon ranged from 2880-4820mk/Kg using HPLC [<a href="#CR70" rid="CR70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921177">70</a>]. Wang and colleagues using a validated Ultra Performance Liquid Chromatography (UPLC) demonstrated the coumarin content of true cinnamon is minimal, amounting to only 0.017&#x000a0;g/Kg, while that of other species of cinnamon varied from 0.31 to 6.97&#x000a0;g/kg [<a href="#CR68" rid="CR68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704532">68</a>]. In 1988 the Council of the European Communities set a maximum limit of 2&#x000a0;mg/kg for coumarin in many foods and beverages [<a href="#CR68" rid="CR68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704537">68</a>].</p><p id="__p84" class="p p-last">This high coumarin content of C. cassia and other species has led some agencies to advocate against the regular use of cassia cinnamon as a supplement in diabetes [<a href="#CR71" rid="CR71" class=" bibr popnode">71</a>]. On the other hand, the very low content of coumarins found in <em>Cinnamomum zeylanicum</em> makes it a potentially useful medication or supplement for long-term use.</p></div><div id="Sec19" class="sec sec-last"><h3>Effective preparations and dose</h3><p id="__p85" class="p p-first">Different clinical trials have used different preparations of cinnamon. In human subjects, <em>Cinnamomum cassia</em> is the only species of cinnamon that has been used and true cinnamon or <em>Cinnamomum zeylanicum</em> has not been studied.</p><p id="__p86">All the studies discussed utilized a powdered form of cinnamon except the studies by Mang et al and Crawford which used an aqueous extract of cinnamon and a commercially available preparation of cinnamon respectively [<a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704497">57</a>, <a href="#CR59" rid="CR59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704485">59</a>].</p><p id="__p87" class="p p-last">Doses varying from 500&#x000a0;mg to 6&#x000a0;g of cinnamon have been used in studies. However the full dose range seems to be effective and the hypoglycaemic effect is not dose dependent [<a href="#CR62" rid="CR62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704538">62</a>].</p></div></div><div id="Sec20" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec20title">Discussion</h2><p id="__p88" class="p p-first">The in-vivo and in-vitro studies discussed had evidence favoring the ability of cinnamon either in dried powder or aqueous extract forms to improve cellular glucose metabolism. Many mechanisms, such as increased autophosphorylation of the insulin receptor, increasing GLUT-4 receptor sysnthesis and enhancing its membrane translocation, inhibition of pancreatic and intestinal amylase and glucosidase and increasing hepatic glycogen synthesis are probably responsible for this effect.</p><p id="__p89">The studies that described individual mechanisms of action were either in vitro studies or studies that utilized small numbers of experimental animals or healthy human volunteers. The evidence from these studies still remains weak, as the evidence has often been not replicated and some times remained contradictory. Clinical trials have so far not attempted to link the clinical outcomes to presumed mechanism of action. While individual actions of cinnamon are described, the relevance of each mechanism to clinically significant outcomes remains unknown. Future studies should focus upon linking clinical outcomes to mechanistic actions thereby making it more relevant in a physiological context.</p><p id="__p90">The stretpozotocin induced diabetic rat model has demonstrated the ability of cinnamon to normalize glucose metabolism, lipid abnormalities and weight changes associated with diabetes. Most of the trials on animal studies showed the ability of cinnamon to reduce FPG, postprandial glucose and or HbA1c [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921183">34</a>, <a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704482">49</a>, <a href="#CR52" rid="CR52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704451">52</a>]. Cinnamon did not seem to reduce plasma glucose of normal rats compared to diabetic rats [<a href="#CR50" rid="CR50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704541">50</a>]. In animal models fed high fructose diets the hyperinsilinaemia, FPG, elevated total cholesterol and triglycerides normalized following treatment with cinnamon [<a href="#CR51" rid="CR51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921175">51</a>]. This effectively demonstrates the normalization of the biochemical parameters of an insulin resistant animal model.</p><p id="__p91">However, the clinical trials have proven more difficult to interpret and the results have been more heterogeneous and conflicting.</p><p id="__p92">All studies discussed, had patients with widely varying baseline characteristics such as age, gender and duration since diagnosis; and direct comparison and generalizations may not be valid between studies. There may have been other confounders such as social habits, ethnicity and dietary substances that influenced the action of cinnamon. Although the active ingredient responsible for glucose lowering has not been characterized with certainty, studies have shown that the concentrations cinnamaldehyde vary between species and even among formulations [<a href="#CR72" rid="CR72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704502">72</a>]. Consequently it would be difficult to achieve predictable results in clinical trials. Additionally variations in the manufacturing process also affect the quality and availability of the active compound, as these complementary products manufacture is not governed to the same exacting standards of conventional pharmacological products.</p><p id="__p93">Akilen et al and Crawford [<a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704557">57</a>, <a href="#CR60" rid="CR60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704481">60</a>] demonstrated significant reductions in HbA1c with cinnamon use. The baseline HbA1c values for the Crawford and Akilen studies were 8.28&#x000a0;% and 8.55&#x000a0;% respectively. However the Crawford study utilized off the shelf cinnamon capsules from varied sources and the purity and content of cinnamon is not known. A placebo group was not present in this study and the results were compared against a group of patients receiving standard care.</p><p id="__p94">It is interesting to note that the trials that failed to demonstrate a significant decline in HbA1c had a mean baseline HbA1c value close to 7&#x000a0;%. (range of 6.8&#x000a0;% to 7.1&#x000a0;%) [<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704466">55</a>, <a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704471">56</a>].</p><p id="__p95">Perhaps a valid explanation for these results would be that the effect of cinnamon is minimal when glucose control is closer to normal and that it exerts a significant effect in reducing glucose as the values increase.</p><p id="__p96">Similarly Khan et al [<a href="#CR58" rid="CR58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704547">58</a>] in their study which lasted only 40&#x000a0;days, demonstrated a significant reduction in FPG. The HbA1c was not measured in this study. The baseline FPG was 13&#x000a0;mmol/l and 12&#x000a0;mmol/l in the placebo and treatment groups respectively and the study demonstrated the ability of cinnamon to reduce glucose in the presence of higher baseline values.</p><p id="__p97">However, in contrast, when the effect of cinnamon was studied in patients with impaired fasting glucose, 2 contrasting doses of 10&#x000a0;g and 500&#x000a0;mg of cinnamon per day respectively was able to reduce the FPG significantly [<a href="#CR65" rid="CR65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704469">65</a>, <a href="#CR66" rid="CR66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704501">66</a>]. In both these studies, Cinnamon was used as the sole agent that had an impact on blood glucose, in contrast to the RCTS which used cinnamon as an add-on therapy to background hypoglycaemic medications. The background therapy in these studies included oral hypoglycaemic agents prescribed as monotherapy or a combination of medications. This raises the possibility that the glucose lowering potential of cinnamon may have been masked in the RCTS when it was used in conjunction with more potent medications as opposed to being used alone.</p><p id="__p98">The negative outcome of the trial performed by Vanschoonbeek [<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704464">55</a>] may be attributable to the short duration of 6&#x000a0;weeks, which may have given rise to a false negative HbA1C result. As the life span of red cells is around 120&#x000a0;days, duration of 2-3 months is required to demonstrate a change in HbA1c levels.</p><p id="__p99">A recent Cochrane meta-analysis found that Cinnamon Cassia used in 8 RCTs in 338 patients did not significantly lower the FPG. Similarly there was no significant reduction in HbA1c, in 6 RCTs that studied the effect of Cinnamon on 405, type 2 adult diabetic patients [<a href="#CR64" rid="CR64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704550">64</a>].</p><p id="__p100">Hlebowicz demonstrated the potential of cinnamon to delay gastric emptying and concluded that the fall in postprandial plasma glucose in subjects who received cinnamon was disproportionate to the delay induced in gastric emptying [<a href="#CR47" rid="CR47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921161">47</a>]. This raises the possibility of a dual mechanism in managing the postprandial glucose surge of diabetic patients; namely the delayed gastric emptying and the inhibition of pancreatic &#x003b1;-amylase and intestinal &#x003b1;-glucosidase.</p><p id="__p101">The safety of long-term supplementation using Cinnamon cassia has been highlighted recently due to its high coumarin content [<a href="#CR68" rid="CR68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704527">68</a>]. However, <em>Cinnamomum zeylanicum</em>, which only contains trace amounts of coumarins, has not been used in clinical trials. If this form of cinnamon is found to be an effective agent in lowering plasma glucose, the low toxicity figures make it an ideal supplement for long-term use.</p><p id="__p102">Both animal and clinical trials published so far have studied the effect of cinnamon for short durations only. In the clinical trials the maximum length of exposure was recorded by Mang, which lasted for 4&#x000a0;months. Although the adverse events recorded in these studies are minimal, these need to be recorded over longer periods of time with a larger population base.</p><p id="__p103">Some clinical trials have used large doses of cinnamon (6-10&#x000a0;g/day) and the long-term outcomes of such measures need to be studied.</p><p id="__p104" class="p">From a safety point of view, there is the potential to use true cinnamon or Ceylon cinnamon for supplementation in view of its low coumarin content. However there are no clinical trials that demonstrate its efficacy, and should be addressed in future clinical trials.</p><div id="Sec21" class="sec sec-last"><h3>Integrative medicine and cinnamon</h3><p id="__p105" class="p p-first-last">Integrative medicine&#x02014;an approach that combines conventional and alternative therapies with an emphasis on natural, less invasive evidence-based options&#x02014;is well suited to the management of complex chronic diseases like type 2 diabetes mellitus [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704514">16</a>]. Published research in the field of this new discipline is extremely sparse but many academic institutions offer information, counseling and clinical therapy sessions [<a href="#CR73" rid="CR73" class=" bibr popnode">73</a>, <a href="#CR74" rid="CR74" class=" bibr popnode">74</a>]. Previous work has shown that patients often do not disclose the complementary medicines they use to their physicians but practice these remedies on their own [<a href="#CR75" rid="CR75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704534">75</a>&#x02013;<a href="#CR77" rid="CR77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921172">77</a>]. The common reasons for non-disclosure seem to be the passive or negative attitudes towards CAM by conventional physicians and their failure to enquire from patients regarding CAM use [<a href="#CR75" rid="CR75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561704472">75</a>, <a href="#CR77" rid="CR77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584921173">77</a>]. However the focus in integrative medicine would be to allow evidence-based complementary practices alongside conventional therapy, thus empowering the patient to be a contributor of the management team. Conventional health care teams would need to be knowledgeable as well as acknowledge these evidence-based complementary practices. Cinnamon has the potential to be practiced as an integrative medicine in instances of mild diabetes where monotherapy is only required. Similarly it may have a place in instances of high initial FPG values and high HbA1C. Further research on the safety and efficacy of cinnamon as well as the feasibility of it as a component of integrative medicine needs to be performed.</p></div></div><div id="Sec22" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec22title">Conclusion</h2><p id="__p106" class="p p-first-last">Both true cinnamon and cassia cinnamon has the potential to lower blood glucose in animal models and humans. Short duration of studies and poor design has made the available evidence difficult to interpret. Ceylon cinnamon has not been studied in humans and its low coumarin content particularly makes it an ideal supplement. Well-designed trials with adequate power to interpret the endpoints are urgently required.</p></div><div id="idm140320764627248" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140320764627248title">Acknowledgements</h2><div class="sec"><p id="__p122">The author wishes to thank Dr. Ameena Sulaeiman and Dr. Heshan Widanapathirana for their assistance in preparation of the tables and figures.</p></div></div><div id="idm140320707582368" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140320707582368title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>CAM</td><td>Complementary and alternative medicine</td></tr><tr><td>BMI</td><td>Body mass index</td></tr><tr><td>GLUT4</td><td>Glucose transporter type 4</td></tr><tr><td>FPG</td><td>Fasting plasma glucose</td></tr><tr><td>PPAR</td><td>Perxisome proliferator-activated receptors</td></tr><tr><td>IRSs</td><td>Insulin receptor substrates</td></tr><tr><td>PI3K</td><td>Phosphatidylinositol 3-kinase</td></tr><tr><td>PK</td><td>Pyruvate kinase</td></tr><tr><td>PEPCK</td><td>Phosphenol Pyruvate Carboxikinase</td></tr></tbody></table></div></div></div><div id="idm140320720651600" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140320720651600title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140320720651472"><p id="__p116" class="p p-first"><strong>Competing interests</strong></p><p id="__p117" class="p p-last">The author declares that he has no competing interests.</p></p><p class="fn sec" id="idm140320764630352"><p id="__p118" class="p p-first"><strong>Authors&#x02019; contributions</strong></p><p id="__p119" class="p p-last">AM was involved in the literature survey, analysis and evaluation of the data and preparation of the manuscript.</p></p><p class="fn sec" id="idm140320764628960"><p id="__p120" class="p p-first"><strong>Author information</strong></p><p id="__p121" class="p p-last">AM is a Senior Lecturer in Medicine, a Consultant Physician and a diabetologist working in charge of a large diabetes care facility at a leading tertiary care institution in Sri Lanka. The community that this facility caters for is semi urban and rural with wide spread traditional practices.</p></p></div></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Vinitha M, Ballal M. In vitro anticandidal activity of Cinnamomum verum. <span><span class="ref-journal">J Med Sci. </span>2008;<span class="ref-vol">8</span>:425–428. doi: 10.3923/jms.2008.425.428.</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3923%2Fjms.2008.425.428" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Shan B, Cai YZ, Brooks DJ. Antibacterial properties and major bioactive component of cinnamon stick (Cinnamomum burmannii): activity against food has borne pathogenic bacteria. <span><span class="ref-journal">J Agric Food Chem. </span>2007;<span class="ref-vol">55</span>:5484–5490. doi: 10.1021/jf070424d.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17567030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1021%2Fjf070424d" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Medagama AB, Bandara R. The use of Complementary and Alternative Medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective? <span><span class="ref-journal">Nutr J. </span>2014;<span class="ref-vol">13</span>(1):102. doi: 10.1186/1475-2891-13-102.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4210501/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25331834" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2F1475-2891-13-102" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Jayaprakasha GK, Rao LJ. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. <span><span class="ref-journal">Crit Rev Food Sci Nutr. </span>2011;<span class="ref-vol">51</span>(6):547–62. doi: 10.1080/10408391003699550.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21929331" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1080%2F10408391003699550" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Rafehi H, Ververis K, Karagiannis TC. Controversies surrounding the clinical potential of cinnamon for the management of diabetes. <span><span class="ref-journal">Diabetes Obes Metab. </span>2012;<span class="ref-vol">14</span>(6):493–9. doi: 10.1111/j.1463-1326.2011.01538.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22093965" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1463-1326.2011.01538.x" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Brahmachari S, Jana A, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. <span><span class="ref-journal">J Immunol. </span>2009;<span class="ref-vol">183</span>(9):5917–27. doi: 10.4049/jimmunol.0803336.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2862570/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19812204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.4049%2Fjimmunol.0803336" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. <span><span class="ref-journal">Annu Rev Nutr. </span>2010;<span class="ref-vol">30</span>:173–99. doi: 10.1146/annurev.nutr.012809.104755.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3144156/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20420526" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1146%2Fannurev.nutr.012809.104755" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="mixed-citation">World Health Organization. WHO Diabetes fact sheet No 312; available at <a href="http://www.who.int/mediacentre/factsheets" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.who.int/mediacentre/factsheets</a>. 2013 0ctober.</span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Ranasinghe P, Jayawardena R, Galappathy P, Constantine GR, de Vas gunawardena N, Katulanda P. Efficacy and safety of &#x02018;true&#x02019; cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. <span><span class="ref-journal">Diabet Med. </span>2012;<span class="ref-vol">29</span>(12):1480–92. doi: 10.1111/j.1464-5491.2012.03718.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22671971" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1464-5491.2012.03718.x" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Cramer JA. A systematic review of adherence with medications for diabetes. <span><span class="ref-journal">Diabetes Care. </span>2004;<span class="ref-vol">27</span>(5):1218–24. doi: 10.2337/diacare.27.5.1218.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15111553" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2337%2Fdiacare.27.5.1218" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Garrow D, Egede LE. Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes. <span><span class="ref-journal">Diabetes care. </span>2006;<span class="ref-vol">29</span>(1):15–19. doi: 10.2337/diacare.29.01.06.dc05-1448.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16373889" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2337%2Fdiacare.29.01.06.dc05-1448" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complimentary and alternative medicine use among adults with diabetes in the United Sates. <span><span class="ref-journal">Altern Ther Health Med. </span>2006;<span class="ref-vol">12</span>(5):16–22.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17017751" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Vuksan V, Sievenpiper JL, Koo VY, Francis JL. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. <span><span class="ref-journal">Arch Intern Med. </span>2000;<span class="ref-vol">160</span>(7):1009–13. doi: 10.1001/archinte.160.7.1009.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10761967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1001%2Farchinte.160.7.1009" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. <span><span class="ref-journal">Complement Ther Med. </span>2001;<span class="ref-vol">9</span>(1):2–11. doi: 10.1054/ctim.2000.0407.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11264963" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1054%2Fctim.2000.0407" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Herman PM. Evaluating the economics of complementary and integrative medicine. <span><span class="ref-journal">Glob Adv Health Med. </span>2013;<span class="ref-vol">2</span>(2):56–63.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3833528/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24416664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Redmer J, Longmier E, Wedel P. Targeting diabetes: the benefits of an integrative approach. <span><span class="ref-journal">J Fam Pract. </span>2013;<span class="ref-vol">62</span>(7):337–44.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23957026" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Choi K, Kim YB. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. <span><span class="ref-journal">Korean J Intern Med. </span>2010;<span class="ref-vol">25</span>(2):119–29. doi: 10.3904/kjim.2010.25.2.119.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2880683/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20526383" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3904%2Fkjim.2010.25.2.119" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Russell RR, 3rd, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. <span><span class="ref-journal">Am J Phys. </span>1999;<span class="ref-vol">277</span>:H643–647.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10444490" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Shen YIto Y, Muraki E, Honoso T, Seki T. Cinnamon extract enhances glucose uptake in 3 T3&#x02013;L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>(2) doi: 10.1371/journal.pone.0087894.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3925101/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24551069" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1371%2Fjournal.pone.0087894" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="mixed-citation">Anderson RA, Zhan Z, Luo R, Guo X, Guo Q, Zhou J, Kong J, Davis PA, Stoecker BJ. Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose. J Tradit Compl Med. 2015; doi: 10.1016/j.jtcme.201503.005.</span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Subash Babu P, Prabuseenivasan S, Ignacimuth S. Cinnamaldehyde-A potential antidiabetic agent. <span><span class="ref-journal">Phytomedcine. </span>2007;<span class="ref-vol">14</span>:15–22. doi: 10.1016/j.phymed.2006.11.005.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17140783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.phymed.2006.11.005" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Ji B, Zhao Y, Zhang Q, Wang P, Guan J, Rong R, et al.  Simultaneous determination of cinnamaldehyde, cinnamic acid, and 2-methoxy cinnamic acid in rat whole blood after oral administration of volatile oil of Cinnamoni Ramulus by UHPLC-MS/MS: An application for a pharmacokinetic study. <span><span class="ref-journal">J Chromatogr B Analyt Technol Biomed Life Sci. </span>2015;<span class="ref-vol">1001</span>:107–13. doi: 10.1016/j.jchromb.2015.07.049.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26262602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.jchromb.2015.07.049" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Chen Y, Ma Y, Ma W. Pharmacokinetics and bioavailability of cinnamic acid after oral administration of Ramulus Cinnamomi in rats. <span><span class="ref-journal">Eur J Drug Metab Pharmacokinet. </span>2009;<span class="ref-vol">34</span>(1):51–6. doi: 10.1007/BF03191384.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19462929" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1007%2FBF03191384" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Anderson RA, Broadhurst CL, Polnasky MM, Schmidt WF, Khan A, Flanagan VP, et al.  Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. <span><span class="ref-journal">J Agric Food Chem. </span>2004;<span class="ref-vol">52</span>(1):65–70. doi: 10.1021/jf034916b.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14709014" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1021%2Fjf034916b" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Goldfine ID. The Insulin Receptor: Molecular Biology and Transmembrane Signaling. <span><span class="ref-journal">Endocrinol Rev. </span>1987;<span class="ref-vol">8</span>(3):235–255. doi: 10.1210/edrv-8-3-235.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/3308443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1210%2Fedrv-8-3-235" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">White FM, Kahn CR. The Insulin Signaling System. <span><span class="ref-journal">Journal of Biochemistry. </span>1994;<span class="ref-vol">269</span>(1):1–4.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/8276779" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Imparl-Radosevich J, Deas S, Polansky MM, Beadke DA, Ingebrsiten TS, Anderson RA, et al.  Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. <span><span class="ref-journal">Horm Res. </span>1998;<span class="ref-vol">50</span>(3):177–82. doi: 10.1159/000023270.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9762007" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1159%2F000023270" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Taher M, Fadzilah Adibah AM, Mohomad RS. A proanthocyanidin from Cinnamomum zeylanicum stimulates phosphorylation of insulin receptor in 3&#x000a0;T3-L1 adipocytes. <span><span class="ref-journal">J Teknologi. </span>2006;<span class="ref-vol">44</span>:53–68.</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Shepherd PR, Kahn BB. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. <span><span class="ref-journal">N Engl J Med. </span>1999;<span class="ref-vol">341</span>(4):248–57. doi: 10.1056/NEJM199907223410406.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10413738" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1056%2FNEJM199907223410406" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="mixed-citation">Nikzamir A, Palangi A, Kheirollaha A, Tabar H, Malakaskar A, Shahbazian H, et al. Expression of Glucose Transporter 4 (GLUT4) is Increased by Cinnamaldehyde in C2C12 Mouse Muscle Cells. Iranian Red Cresecent Med J. 2014;16(2), e13426. <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3965863/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24719730" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3&#x000a0;T3-L1 adipocytes. <span><span class="ref-journal">Arch Biochem Biophys. </span>2007;<span class="ref-vol">459</span>(2):214–22. doi: 10.1016/j.abb.2006.12.034.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17316549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.abb.2006.12.034" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. <span><span class="ref-journal">Diabetes Res Clin Pract. </span>2003;<span class="ref-vol">62</span>(3):139–48. doi: 10.1016/S0168-8227(03)00173-6.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14625128" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2FS0168-8227(03)00173-6" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="mixed-citation">Shen Y, Fukushima M, Ito Y, Muraki E, Hosono T, Seki T, et al. Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci Biotechnol Biochem. 2010;74:2418&#x02013;25.  <span class="nowrap ref pubmed">[<a href="/pubmed/21150113" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Anand P, Murali K, Tandon V, Murthy PS, Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. <span><span class="ref-journal">Chemico-Biolog Interact. </span>2010;<span class="ref-vol">186</span>:72–81. doi: 10.1016/j.cbi.2010.03.044.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20363216" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.cbi.2010.03.044" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Shetty M, Loeb JN, Vikstrom K, Ismail-Beigi F. Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells. <span><span class="ref-journal">J Biol Chem. </span>1993;<span class="ref-vol">268</span>(23):17225–32.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/8349608" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="mixed-citation">Liong E, Kong SK, Au KK, Li JY, Xu GY, Lee YL, et al. Inhibition of glucose uptake and suppression of glucose transporter 1 mRNA expression in L929 cells by tumor necrosis factor-alpha. Life Sci. 1999;65:PL215&#x02013;20.  <span class="nowrap ref pubmed">[<a href="/pubmed/10574229" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Plaisier C, Cock A, Scott J, Opejin A, Bushhouse KT, Salie MJ, et al.  Effects of cinnamaldehyde on the glucose transport activity of GLUT1. <span><span class="ref-journal">Biochimie. </span>2011;<span class="ref-vol">93</span>(2):339–44. doi: 10.1016/j.biochi.2010.10.006.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3019305/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20955755" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.biochi.2010.10.006" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Plexopathy DL. Cinnamon dose-dependently reduces insulin concentration. <span><span class="ref-journal">Am J Clin Nutr. </span>2009;<span class="ref-vol">89</span>:815–21. doi: 10.3945/ajcn.2008.26807.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19158209" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3945%2Fajcn.2008.26807" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Hlebowicz J, Hlebowicz A, Lindstedt S, Bjorgell O, Hoglund P, Hoist JJ, et al.  Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. <span><span class="ref-journal">Am J Clin Nutr. </span>2009;<span class="ref-vol">89</span>(3):815–21. doi: 10.3945/ajcn.2008.26807.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19158209" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3945%2Fajcn.2008.26807" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. <span><span class="ref-journal">Endocr Rev. </span>1999;<span class="ref-vol">20</span>(5):649–88.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10529898" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="mixed-citation">Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet. 2001;357(9260):905-10.  <span class="nowrap ref pubmed">[<a href="/pubmed/11289345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Olefsky JM. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. <span><span class="ref-journal">J Clin Invest. </span>2000;<span class="ref-vol">106</span>(4):467–72. doi: 10.1172/JCI10843.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC380259/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10953021" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1172%2FJCI10843" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Miyazaki Y, Mahankali A, Matsuda M, Glass S, Mahankali S, Ferrannini E, et al.  Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. <span><span class="ref-journal">Diabetes Care. </span>2001;<span class="ref-vol">24</span>(4):710–9. doi: 10.2337/diacare.24.4.710.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11315836" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2337%2Fdiacare.24.4.710" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. <span><span class="ref-journal">PPAR Res. </span>2008;<span class="ref-vol">2008</span>:581348. doi: 10.1155/2008/581348.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2602825/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19096709" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1155%2F2008%2F581348" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Adisakwattana S, Lerdsuwankij O, Poputtachai U, Minipun A, Suparpprom C. Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal &#x003b1;-glucosidase and pancreatic &#x003b1;-amylase. <span><span class="ref-journal">Plant Foods Hum Nutr. </span>2011;<span class="ref-vol">66</span>:143–148. doi: 10.1007/s11130-011-0226-4.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21538147" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1007%2Fs11130-011-0226-4" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Ranilla LG, Kwon YI, Apostolidis E, Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. <span><span class="ref-journal">Bioresour Technol. </span>2010;<span class="ref-vol">101</span>:4676–4689. doi: 10.1016/j.biortech.2010.01.093.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20185303" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.biortech.2010.01.093" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Hlebowicz J, Darwiche G, Bjorgell O, Almer LO. Effect of cinnamon on post prandial blood glucose, gastric emptying and and satiety in healthy subjects. <span><span class="ref-journal">Am J Clin Nutr. </span>2007;<span class="ref-vol">85</span>(6):969–76.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17556692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Zari TA, A.-L.A  Long-term effects of Cinnamomum zeylanicum Blume oil on some physiological parameters in Streptozotocin -diabetic and non-diabetic rats. <span><span class="ref-journal">Bol Latinoam Caribe Plantas. </span>2009;<span class="ref-vol">8</span>:266–274.</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Subash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde--a potential antidiabetic agent. <span><span class="ref-journal">Phytomedicine. </span>2007;<span class="ref-vol">14</span>(1):15–22. doi: 10.1016/j.phymed.2006.11.005.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17140783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.phymed.2006.11.005" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Ranasinghe P, Perera S, Gunatilake M, Abeywardena E, Gunapala N, Premakumara S, et al.  Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. <span><span class="ref-journal">Pharmacognosy Res. </span>2012;<span class="ref-vol">4</span>(2):73–9. doi: 10.4103/0974-8490.94719.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3326760/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22518078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.4103%2F0974-8490.94719" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="mixed-citation">Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J. 2006;47(10):858&#x02013;63.  <span class="nowrap ref pubmed">[<a href="/pubmed/16990960" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Shihabudeen MS, Hansi Priscilla D, Thirumurugan K. Cinnamon extract inhibits alpha-lucosidase and dampens posprandial glucose excursions in diabetic rats. <span><span class="ref-journal">Nutr Metab (Lond) </span>2011;<span class="ref-vol">8</span>:46. doi: 10.1186/1743-7075-8-46.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3155477/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21711570" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2F1743-7075-8-46" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Shalaby MA, Saifan HY. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. <span><span class="ref-journal">J intercult Ethnopharmcol. </span>2014;<span class="ref-vol">3</span>:144–9.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4576807/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26401364" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Suppapitiporn S, Kanpaksi N, Suppapitiporn S. The effect of cinnamon cassia powder in type 2 diabetes mellitus. <span><span class="ref-journal">J Med Assoc Thai. </span>2006;<span class="ref-vol">89</span>(3):S200–205.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17718288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. <span><span class="ref-journal">J Nutr. </span>2006;<span class="ref-vol">136</span>:977–980.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16549460" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Blevins SM, Leyva MJ, Brown J, Wright J, Scofield RH, Aston CE. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. <span><span class="ref-journal">Diabetes Care. </span>2007;<span class="ref-vol">30</span>(9):2236–7. doi: 10.2337/dc07-0098.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17563345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2337%2Fdc07-0098" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. <span><span class="ref-journal">J Am Board Fam Med. </span>2009;<span class="ref-vol">22</span>(5):507–12. doi: 10.3122/jabfm.2009.05.080093.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19734396" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3122%2Fjabfm.2009.05.080093" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR58">58. <span class="element-citation">Khan A, Sadafar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. <span><span class="ref-journal">Diabetes Care. </span>2003;<span class="ref-vol">26</span>(12):3215–8. doi: 10.2337/diacare.26.12.3215.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14633804" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.2337%2Fdiacare.26.12.3215" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR59">59. <span class="element-citation">Mang B, Wolters M, Schmitt M, Kelb K, Lichtinghagen R, Stichtenoth DO. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. <span><span class="ref-journal">Eur J Clin Invest. </span>2006;<span class="ref-vol">36</span>(5):340–4. doi: 10.1111/j.1365-2362.2006.01629.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16634838" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1365-2362.2006.01629.x" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR60">60. <span class="element-citation">Akilen R, Tsiami A, Devendra D, Robinson N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. <span><span class="ref-journal">Diabet Med. </span>2010;<span class="ref-vol">27</span>(10):1159–67. doi: 10.1111/j.1464-5491.2010.03079.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20854384" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1464-5491.2010.03079.x" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR61">61. <span class="element-citation">Khan R, Khan Z, Shah S. Cinnamon may reduce glucose, lipid and cholesterol level in type 2 diabetic individuals. <span><span class="ref-journal">Pakistan J Nutr. </span>2010;<span class="ref-vol">9</span>(5):430–433. doi: 10.3923/pjn.2010.430.433.</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.3923%2Fpjn.2010.430.433" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR62">62. <span class="element-citation">Akilen R, Devendra D, Robinson N. Cinnamon in glycaemic control: Systematic review and meta analysis. <span><span class="ref-journal">Clin Nutr. </span>2012;<span class="ref-vol">31</span>(5):609–15. doi: 10.1016/j.clnu.2012.04.003.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22579946" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.clnu.2012.04.003" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR63">63. <span class="element-citation">Allen WR, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in Type 2 diabetes: an updated systematic review and meta analysis. <span><span class="ref-journal">Ann Fam Med. </span>2013;<span class="ref-vol">11</span>(5):452–459. doi: 10.1370/afm.1517.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3767714/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24019277" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1370%2Fafm.1517" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR64">64. <span class="element-citation">Leach MJ, Kumar S. Cinnamon for diabetes mellitus. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2012;<span class="ref-vol">9</span></span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22972104" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR65">65. <span class="element-citation">Roussel AM, Hinniger I, Benaraba R, Ziegenfuss TN, Anderson RA. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. <span><span class="ref-journal">J Am Coll Nutr. </span>2009;<span class="ref-vol">28</span>(1):16–21. doi: 10.1080/07315724.2009.10719756.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19571155" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1080%2F07315724.2009.10719756" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR66">66. <span class="element-citation">Ziegenfuss TN. hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. <span><span class="ref-journal">J Int Soc Sports Nutr. </span>2006;<span class="ref-vol">3</span>:45–53. doi: 10.1186/1550-2783-3-2-45.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2129164/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18500972" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2F1550-2783-3-2-45" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR67">67. <span class="element-citation">Al-Logmani AS, Zari TA. Effects of Nigella sativa L. and Cinnamomum zeylanicum Blume oils on some physiological parameters in streptozotocin-induced diabetic rats. <span><span class="ref-journal">Bol Latinoam Caribe Plantas. </span>2009;<span class="ref-vol">186</span>:86–96.</span></span></div><div class="ref-cit-blk half_rhythm" id="CR68">68. <span class="element-citation">Wang YH, Avula B, Nanayakkara NP, Zhao J, Khan IA. Cassia Cinnamon as a Source of Coumarin in Cinnamon-Flavored Food and Food Supplements in the United States. <span><span class="ref-journal">J Agric Food Chem. </span>2013;<span class="ref-vol">61</span>(18):4470–6. doi: 10.1021/jf4005862.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23627682" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1021%2Fjf4005862" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR69">69. <span class="element-citation">Abraham K, Wohrlin F, Lindtner O, Heinemeyer G, Lampen A. Toxicology and risk assessment of coumarin: focus on human data. <span><span class="ref-journal">Mol Nutr Food Res. </span>2010;<span class="ref-vol">54</span>(2):228–39. doi: 10.1002/mnfr.200900281.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20024932" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fmnfr.200900281" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR70">70. <span class="mixed-citation">Sproll C, Ruge W, Andlauer C, Godelmann R, Lahenmeier DW. HPLC analysis and safety assessment of coumarin in foods. Food Chem. 2008;109(2):462&#x02013;9.  <span class="nowrap ref pubmed">[<a href="/pubmed/26003373" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR71">71. <span class="element-citation">European Food Safety Association  Coumarin in flavourings and other food ingredients with flavouring properties. <span><span class="ref-journal">EFSA J. </span>2008;<span class="ref-vol">793</span>:1–15.</span></span></div><div class="ref-cit-blk half_rhythm" id="CR72">72. <span class="element-citation">Corns CM. Herbal remedies and clinical biochemistry. <span><span class="ref-journal">Ann Clin Biochem. </span>2003;<span class="ref-vol">40</span>(Pt 5):489–507. doi: 10.1258/000456303322326407.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14503986" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1258%2F000456303322326407" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR73">73. <span class="mixed-citation">University of Colorado,. Center for Integrative Medicine 2015; Available from: <a href="https://www.uchealth.org/Pages/services/integrative-Medicine.aspx" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">https://www.uchealth.org/Pages/services/integrative-Medicine.aspx</a>.</span></div><div class="ref-cit-blk half_rhythm" id="CR74">74. <span class="mixed-citation">University of Kansas., integrative medicine. 2015; available from: <a href="http://www.kumc.edu/school-of-medicine/integrative-medicine.html" ref="reftype=extlink&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.kumc.edu/school-of-medicine/integrative-medicine.html</a>.</span></div><div class="ref-cit-blk half_rhythm" id="CR75">75. <span class="element-citation">Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women's views, knowledge and interaction with doctors: a qualitative study. <span><span class="ref-journal">BMC Complement Altern Med. </span>2006;<span class="ref-vol">6</span>:40. doi: 10.1186/1472-6882-6-40.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1702550/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17156416" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2F1472-6882-6-40" target="pmc_ext" ref="reftype=other&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR76">76. <span class="mixed-citation">Bhalerao MS, Bolshete PM, Swar BD, Banger TA, Kolhe VR, Tambe MJ.&#x000a0; Use of and satisfaction with complementary and alternative medicine in four chronic diseases: a cross-sectional study from India. Natl Med J India. 2013;26(2):75&#x02013;8.  <span class="nowrap ref pubmed">[<a href="/pubmed/24093979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR77">77. <span class="mixed-citation">Chang HA, Wallis M, Tiralongo E. Use of Complementary and Alternative Medicine among People with Type 2 Diabetes in Taiwan: A Cross-Sectional Survey. Evid Based Complement Alternat Med. 2011. 2011. doi: 10.1155/2011/983792 <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2952338/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20953402" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4609100&amp;issue-id=247585&amp;journal-id=128&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Nutrition Journal</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4609100/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4609100/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4609100/pdf/12937_2015_Article_98.pdf">PDF (751K)</a></li> | <li><a href="#" data-citationid="PMC4609100" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4609100%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4609100%2F&amp;text=The%20glycaemic%20outcomes%20of%20Cinnamon%2C%20a%20review%20of%20the%20experimental%20evidence%20and%20clinical%20trials"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4609100%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="26475130" data-aiid="4609100" data-aid="4609100" data-iid="247585" data-domainid="128" data-domain="nutrj" data-accid="PMC4609100" data-md5="c3245b31a690cb5824dfd476995e8507"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-09-07T04:07:26-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc201&amp;ncbi_phid=F4FB3FE3B9231B810000000000040004&amp;ncbi_session=F4FB3FE3B9231BE1_0004SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4609100%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nutrj&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4609100/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FB3FE3B9231BE1_0004SID /projects/PMC/PMCViewer@4.46 ptpmc201 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>